JUNE 8, 2022
Brinter was presenting at BioscienceLA for various companies, research organizations and hospitals today, and especially interesting meeting we had with City of Hope and Daniela Castanotto about our cancer research and precision oncology solutions.
Brinter’s priority protocols are in precision oncology and working with 3D bioprinted cancer/organoid models or avatars, as we like to call them. These cancer models have a potential of speeding up locating precision drug for patient by over 30%
By Tom Alapaattikoski, CEO Brinter Inc
-City of Hope has been ranked among the nation’s ‘Best Hospitals’ in cancer by U.S. News & World Report for over a decade.-
